Education
About Us
Working with TipRanks
Follow Us
Firefly Neuroscience (AIFF)
NASDAQ:AIFF
AIFF Stock Chart & Stats
$1.05
-$0.10(-4.05%)
At close: 4:00 PM EST
$1.05
-$0.10(-4.05%)
Day’s Range― - ―
52-Week Range$0.62 - $6.00
Previous CloseN/A
Volume11.65K
Average Volume (3M)316.76K
Market Cap
$9.91M
Enterprise Value$5.59M
Total Cash (Recent Filing)$4.33M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta3.04
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.64
Shares Outstanding14,214,082
10 Day Avg. Volume358,037
30 Day Avg. Volume316,761
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-46.26
Price to Sales (P/S)160.64
P/FCF Ratio-2.64
Enterprise Value/Market Cap0.56
Enterprise Value/Revenue7.13
Enterprise Value/Gross Profit10.83
Enterprise Value/Ebitda-0.29
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Gross Margin ImprovementMaterial revenue growth and a step-up in gross margin indicate improving monetization and unit economics. That progress supports a more sustainable operating model as sales scale, reducing the subsidy per sale and improving the path to break-even if growth persists and fixed costs are controlled.
Clean Balance Sheet (no Debt, Positive Equity)Absence of debt and positive equity materially lowers financial leverage risk, improving solvency and giving management flexibility to raise capital or execute strategic initiatives. This cleaner capital structure reduces near-term default risk versus debt-funded peers.
Scalable AI-enabled Software Business ModelA software platform for clinical and research neurodiagnostics offers scalable unit economics, potential recurring revenues, and defensibility from proprietary algorithms and datasets. Structural demand for objective brain analytics supports multi-year adoption and commercial leverage if clinical validation continues.
Bears Say
High Cash Burn And Negative Free Cash FlowPersistent negative OCF and FCF show the business consumes material cash to operate and grow. That ongoing burn constrains runway, forces recurring capital raises, and limits the company’s ability to fund sales, clinical validation, or product investments without external financing.
Deep Unprofitability And Very Negative MarginsAn extremely negative net margin reflects operating costs far exceeding current revenues, eroding shareholder value and producing negative returns on capital. Until scale or structural cost reductions are achieved, profitability metrics will remain a significant impediment to long-term financial sustainability.
Reliance On External Financing And Dilution RiskRecent warrant restructurings and governance moves to expand authorized shares show the company depends on equity financing to fund operations. That reliance raises dilution risk and can pressure investor alignment, making capital access and favorable terms a recurring strategic challenge.
Firefly Neuroscience News
AIFF FAQ
What was Firefly Neuroscience’s price range in the past 12 months?
Firefly Neuroscience lowest stock price was $0.62 and its highest was $6.00 in the past 12 months.
What is Firefly Neuroscience’s market cap?
Firefly Neuroscience’s market cap is $9.91M.
When is Firefly Neuroscience’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Firefly Neuroscience’s earnings last quarter?
Firefly Neuroscience released its earnings results on May 14, 2024. The company reported -$0.335 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.335.
Is Firefly Neuroscience overvalued?
According to Wall Street analysts Firefly Neuroscience’s price is currently Overvalued.
Does Firefly Neuroscience pay dividends?
Firefly Neuroscience does not currently pay dividends.
What is Firefly Neuroscience’s EPS estimate?
Firefly Neuroscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Firefly Neuroscience have?
Firefly Neuroscience has 14,214,082 shares outstanding.
What happened to Firefly Neuroscience’s price movement after its last earnings report?
Firefly Neuroscience reported an EPS of -$0.335 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.455%.
Which hedge fund is a major shareholder of Firefly Neuroscience?
Currently, no hedge funds are holding shares in AIFF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Technical Analysis
Ownership Overview
8.70% Insiders
3.74% Mutual Funds
0.08% Other Institutional Investors
84.18% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---